ATE180482T1 - Xanthinderivate zur behandlung der demenz - Google Patents

Xanthinderivate zur behandlung der demenz

Info

Publication number
ATE180482T1
ATE180482T1 AT92119080T AT92119080T ATE180482T1 AT E180482 T1 ATE180482 T1 AT E180482T1 AT 92119080 T AT92119080 T AT 92119080T AT 92119080 T AT92119080 T AT 92119080T AT E180482 T1 ATE180482 T1 AT E180482T1
Authority
AT
Austria
Prior art keywords
chem
substituted
same
unsubstituted
different
Prior art date
Application number
AT92119080T
Other languages
English (en)
Inventor
Suzuki Fumio
Shimada Junichi
Kato Hiromasa
Ishii Akio
Shiozaki Shizuo
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE180482T1 publication Critical patent/ATE180482T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92119080T 1991-11-08 1992-11-06 Xanthinderivate zur behandlung der demenz ATE180482T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29326991 1991-11-08

Publications (1)

Publication Number Publication Date
ATE180482T1 true ATE180482T1 (de) 1999-06-15

Family

ID=17792638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92119080T ATE180482T1 (de) 1991-11-08 1992-11-06 Xanthinderivate zur behandlung der demenz

Country Status (5)

Country Link
US (1) US5447933A (de)
EP (1) EP0541120B1 (de)
AT (1) ATE180482T1 (de)
CA (1) CA2082325A1 (de)
DE (1) DE69229257D1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62247149A (ja) * 1986-04-18 1987-10-28 Mitsubishi Electric Corp 内燃機関の燃料制御装置
DE8817122U1 (de) * 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 55218 Ingelheim Neue Xanthinderivate mit Adenosinantogenistischer Wirkung
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
DE4316576A1 (de) * 1993-05-18 1994-11-24 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 1,3-Dipropyl-8-(3-Oxocyclopentyl)-xanthin
WO1995031460A1 (en) * 1994-05-17 1995-11-23 Kyowa Hakko Kogyo Co., Ltd. Process for producing xanthine derivative
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
JP2001523213A (ja) * 1994-12-13 2001-11-20 ユーロ−セルティーク，エス．エイ． 三置換チオキサンチン類
DE69531506T2 (de) * 1994-12-13 2004-06-24 Euroceltique S.A. Arylthioxanthine
WO1996036638A1 (en) * 1995-05-19 1996-11-21 Chiroscience Limited Xanthines and their therapeutic use
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5786360A (en) * 1996-11-19 1998-07-28 Link Technology Incorporated A1 adenosine receptor antagonists
US6248746B1 (en) 1998-01-07 2001-06-19 Euro-Celtique S.A. 3-(arylalkyl) xanthines
US6263850B1 (en) 1999-08-03 2001-07-24 Visteon Global Technologies, Inc. Integrated air induction module for gasoline engines
EP2305684A1 (de) 1999-11-12 2011-04-06 Biogen Idec MA Inc. Polycycloalkylpurine als Adenosinrezeptorantagonisten
CA2390590C (en) 1999-11-12 2010-03-16 Biogen, Inc. Adenosine receptor antagonists and methods of making and using the same
WO2004074247A2 (en) * 2003-02-19 2004-09-02 Endacea, Inc. A1 adenosine receptor antagonists
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
EP1636229A4 (de) * 2003-06-06 2008-07-30 Endacea Inc A1-adenosinrezeptorantagonisten
CA2528367A1 (en) * 2003-06-09 2004-12-23 Endacea, Inc. A1 adenosine receptor antagonists
WO2006091936A2 (en) * 2005-02-25 2006-08-31 Adenosine Therapeutics, Llc Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
EP2061793A2 (de) * 2006-08-22 2009-05-27 Novacardia, Inc. Kw-3902-konjugate, die die blut-hirn-schranke nicht überwinden
US9522916B2 (en) * 2007-12-21 2016-12-20 Constance Neely Wilson A1 adenosine receptor antagonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA724173A (en) * 1965-12-21 Goldner Herbert Process for the production of xanthine derivatives
DE1245969B (de) * 1967-08-03 VEB Arzneimittelwerk Dresden, Radebeul Verfahren zur Herstellung von Xanthinderivaten
US4576947A (en) * 1967-12-16 1986-03-18 Hoechst Aktiengesellschaft Pharmaceutical compositions
FR2558162B1 (fr) * 1984-01-17 1986-04-25 Adir Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
WO1986001724A1 (en) * 1984-09-07 1986-03-27 The General Hospital Corporation Xanthine derivative pest control agents
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
DE8817122U1 (de) * 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 55218 Ingelheim Neue Xanthinderivate mit Adenosinantogenistischer Wirkung
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
JPH06102662B2 (ja) * 1989-09-01 1994-12-14 協和醗酵工業株式会社 キサンチン誘導体
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
CA2061544A1 (en) * 1991-02-25 1992-08-26 Fumio Suzuki Xanthine compounds

Also Published As

Publication number Publication date
DE69229257D1 (de) 1999-07-01
CA2082325A1 (en) 1993-05-09
EP0541120A2 (de) 1993-05-12
EP0541120B1 (de) 1999-05-26
US5447933A (en) 1995-09-05
EP0541120A3 (en) 1993-07-21

Similar Documents

Publication Publication Date Title
DE69229257D1 (de) Xanthinderivate zur Behandlung der Demenz
DE69034202D1 (de) Zwischenprodukte zur Herstellung von non-peptiden retroviralproteasehemmenden Verbindungen
NO20012617D0 (no) Kinolin- og kinzolinderivater
DK260588A (da) Heterocykliske ketoner
NO302755B1 (no) Morfinan-derivater
ATE219766T1 (de) N-acylierte 4-aminopiperidin derivate als aktive bestandteile von peripher gefässerweiternden wikstoffen
DK0444659T3 (da) Farmaceutisk opløsning indeholdende derivater af FK 506
RO93855A (ro) Procedeu pentru prepararea de arilciclobutilalchilamina
DE69406323D1 (de) Substituierte Aminsäure Derivate verwendbar für die Behandlung von Arteriosclerosis
SE8406141D0 (sv) N-acylaminosyradiamidderivat, salter derav, forfarande for deras framstellning och antiulcermedel innehallande dessa
ATE513821T1 (de) Thiadiazolin-derivate zur behandlung von krebs
DE68926981D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
DK0420121T3 (da) Antitumormiddel
FR2612517B1 (fr) Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant
IL103595A0 (en) 2-heterocyclicethylamine derivatives,their preparation and pharmaceutical compositions containing them
DK0420224T3 (da) Anthihepatopatisk middel
ATE94050T1 (de) Mittel zur verhinderung von zahnbelagbildung.
FI883507A0 (fi) Naftotiazepinderivat och deras framstaellning.
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.
DE3572815D1 (de) 1,3-dithiole derivatives
GEP19960472B (en) Method of producing derivative of quinoline or its pharmaceutically acceptable ester, or their salts
DE69022660D1 (de) Verfahren zur Herstellung von Carbamatderivaten des Lankacidines.
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.